Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0780
0.00 (0.00%)
Sep 30, 2026, 3:21 PM EST
Zomedica Revenue
Zomedica had revenue of $9.51M in the quarter ending June 30, 2026, with 36.59% growth. This brings the company's revenue in the last twelve months to $36.88M, up 30.05% year-over-year. In the year 2025, Zomedica had annual revenue of $32.03M with 17.39% growth.
Revenue (ttm)
36.88M
Revenue Growth
+30.05%
P/S Ratio
2.13
Revenue / Employee
261.54K
Employees
141
Market Cap
78.40M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.03M | 4.75M | 17.39% |
| Dec 31, 2024 | 27.29M | 2.10M | 8.33% |
| Dec 31, 2023 | 25.19M | 6.26M | 33.05% |
| Dec 31, 2022 | 18.93M | 14.80M | 358.02% |
| Dec 31, 2021 | 4.13M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| QHSLab | 3.02M |
| Kelyniam Global | 2.67M |
| BioElectronics | 1.61M |
| PetVivo Holdings | 1.18M |
| Tian'an Technology Group | 734.89K |
| Guided Therapeutics | 650.00K |
| Positron | 444.82K |
| Vivos | 99.10K |
Zomedica News
- 9 days ago - Zomedica Announces Strategic Partnership with Veterinary Study Groups (VMG) to Deliver Advanced Veterinary Technologies to Independent Practices - Accesswire
- 22 days ago - Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica's Marketing Engine: How Demand Becomes Revenue - Accesswire
- 4 weeks ago - Zomedica Transcript: Investor update - Transcripts
- 7 weeks ago - Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform - Accesswire
- 7 weeks ago - Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation - Accesswire
- 1 month ago - Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity - Accesswire
- 1 month ago - Zomedica Quarterly report: Q2 2026 - Filings
- 1 month ago - Zomedica Earnings release: Q2 2026 - Filings